Molbio Diagnostics NSE Volume Spurt Clarification
Company Response to NSE Query
Molbio Diagnostics Limited provided a formal clarification to the National Stock Exchange of India Ltd regarding unusual trading activity in its shares. The communication was dated October 19, 2026 and addressed the exchange's surveillance query referenced under NSE/CM/Surveillance/17729 dated October 16, 2026.
Nature of Exchange Query
The NSE sought clarification regarding significant increase in trading volume of the company's shares across both stock exchanges where the company is listed (BSE Limited and National Stock Exchange of India Ltd).
Company's Clarification on Trading Volume
The company stated that the movement in share volume is "purely market driven" and not attributable to any undisclosed company developments. Molbio Diagnostics confirmed that it has disclosed every event required under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Compliance Statement
The company explicitly stated that there is "no announcement or price-sensitive information that is pending to be intimated, furnished or disclosed to the exchanges," indicating full compliance with SEBI listing requirements.